3 Australian Penny Stocks Backed By Strong Earnings And Financial Health

Penny stocks often carry a reputation for high risk, but the Financially Fit Penny Stocks screener focuses on companies trading below 5 that still show signs of solid financial health. That matters when global data is mixed, with some regions reporting stronger manufacturing or cooling inflation and others facing softer activity. Investors who want exposure to early stage opportunities without only relying on speculative stories may find this combination of low share prices and healthier balance sheets helpful. This article highlights 3 screened stocks that stand out for further research.

Ora Banda Mining (ASX:OBM)

Overview: Ora Banda Mining is an Australian resources company focused on exploring, developing and operating gold and other mineral deposits, including nickel, copper and lithium, with its core asset being the 100% owned Davyhurst Gold Project near Kalgoorlie in Western Australia.

Operations: Ora Banda Mining generates A$554.1 million in revenue from gold production and exploration in Australia.

Market Cap: A$2.25b

Ora Banda Mining has caught attention in this screener because it combines strong recent earnings growth with improving mine scale at Davyhurst. Profitability metrics such as a 41.8% net margin and very high current and forecast ROE suggest the existing operations are producing healthy returns. Record quarterly production and a larger resource and reserve base point to more production years ahead if plans stay on track. At the same time, heavy use of external borrowing and high non cash earnings add balance sheet and earnings quality questions that investors should understand. With plans to roughly double output by FY2029 and several key deposits still being drilled out, there is more to the story than the current share price alone implies.

Ora Banda Mining’s rising production story and 41.8% net margin raise big questions about how far current returns can stretch. Get the 4 key rewards and 1 important major warning sign to see what might change the plot next.

DroneShield (ASX:DRO)

Overview: DroneShield develops and sells hardware and software that detect, track and disable unauthorised drones for defence forces, security agencies and critical infrastructure operators across multiple regions including Australia, the United States and Europe. Its products range from wearable drone detectors and handheld jamming devices to fixed-site and software platforms that help customers monitor airspace and respond to threats.

Operations: DroneShield generates A$216.8 million in revenue primarily from its Aerospace and Defense segment, with A$194.99 million reported from Australia and the rest of the world and A$29.73 million from the USA.

Market Cap: A$1.68b

DroneShield gives investors exposure to the counter drone market, with the company supplying defence, security and event protection customers and forecasting revenue and earnings growth. Recent European defence contracts, FIFA World Cup 2026 security work and new products such as the RfAI-3 engine indicate increasing adoption of DroneShield technology. At the same time, earnings are still early stage, ROE is low, funding relies heavily on external borrowing and an ASIC disclosure investigation adds regulatory risk. If management converts its pipeline into more repeat contracts and lifts margins, while the board beds in additional defence experience, the company may become more noteworthy for investors watching this stock.

DroneShield’s accelerating contract wins and new products are only half the story. Get the analyst forecasts for DroneShield to see how its revenue ambitions compare with funding needs and that ASIC investigation twist.

Sigma Healthcare (ASX:SIG)

Overview: Sigma Healthcare is an Australian pharmacy wholesaler and distributor that supplies medicines and health products to community pharmacies, runs franchise pharmacy brands such as Chemist Warehouse, Amcal and Discount Drug Stores, and supports these retailers with logistics and health services, including online channels.

Operations: Sigma Healthcare generates about A$9.55b in revenue from its Healthcare segment, with A$9.16b from Australia and A$389.79m from international markets.

Market Cap: A$34.16b

Sigma Healthcare stands out in this penny stock screener because it combines a large pharmacy distribution footprint with earnings that analysts expect to grow faster than the broader Australian market, backed by a 5 year earnings growth history of 30.8% a year. At the same time, the stock trades on a rich 57x P/E. Profit margins have narrowed from 11.5% to 6.3%, and the balance sheet leans on external borrowing, all while a relatively new management team and board settle in. After stepping back from a potential Boots UK takeover in June 2026 to focus on its core Australian business, the next phase for Sigma Healthcare could look very different to what the current share price suggests.

Sigma Healthcare’s fast earnings track record and 57x P/E suggest investors may be pricing only part of the story. Read the analyst forecasts for Sigma Healthcare to see whether recent margin pressure is a temporary bump or something sharper coming into focus

The three stocks here are only a starting point. The full Financially Fit Penny Stocks screener surfaces 402 more companies that pair low share prices with balance sheets and earnings stories that may be just as compelling. Use Simply Wall St to identify and analyze the specific catalysts and narratives that matter most to you so you can focus on the penny stocks that best match your highest conviction ideas.

Take Control of Your Investment Journey

If Ora Banda Mining or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Curious To Explore Fresh Alternatives?

Some of the most interesting stories can move from quiet to breakout quickly. Consider these fresh stock ideas while the data is still under the radar for now.

• Spot companies with strong income engines before momentum starts flying by scanning the 5 dividend fortresses built to highlight high-yield payouts that still look supported by underlying cash flows.
• Track businesses powering AI infrastructure and monitor the next wave of demand by using the curated 55 AI infrastructure stocks focused on real revenue and mission critical assets.
• Zero in on metals producers positioned for potential demand swings by checking the hand picked 8 top copper producer stocks that filters for balance sheet strength and production quality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com